Examine This Report on Rhodiocyanoside A
Minor (1)quinupristin/dalfopristin will decrease the level or outcome of balsalazide by altering intestinal flora. Applies only to oral form of both equally agents. Minimal/Importance Unidentified.quinupristin/dalfopristin will increase the amount or outcome of acalabrutinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy